Resmed RMD
NYSE RMD
$221.24 +0.14 (+0.06%)
As of: Oct 1, 2026 · 3:59 PM EDT

Resmed (RMD) Income from Continuing Operations (2009 - 2026)

Updated

Resmed's Income from Continuing Operations came in at $383.43 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 1.0% from $379.71 million a year earlier but down 3.8% from the prior quarter.

Analysis

Resmed (RMD) Income from Continuing Operations (2009 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Resmed's Income from Continuing Operations was $1.52 billion, up 8.8% from FY2025.

  • Income from Continuing Operations has increased in each of the last five fiscal years, with a five-year compound annual growth rate of 26.3% (FY2021 to FY2026).
  • Going back by fiscal year, Income from Continuing Operations was $1.4 billion in FY2025 (+37.2%), $1.02 billion in FY2024 (+13.7%), $897.56 million in FY2023 (+15.2%) and $779.44 million in FY2022 (+64.3%).
  • The five-year range for quarterly Income from Continuing Operations is $179.01 million (fiscal Q3 2022) to $398.73 million (fiscal Q3 2026).
  • Year-over-year, Income from Continuing Operations has increased for ten consecutive quarters, with growth averaging 24.3% over the last eight quarters.
  • The fastest year-over-year change in Income from Continuing Operations over five years came in fiscal Q2 2025 (growth of 65.0%), and the weakest in fiscal Q2 2024 (a decline of 7.2%).
  • Business Quant data shows RMD's Income from Continuing Operations at $398.73 million (Q3 2026), $392.59 million (Q2 2026) and $348.54 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 1.76 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 928.00 Mn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 870.00 Mn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 823.20 Mn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 1.48 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -220.00 Mn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 905.00 Mn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 241.40 Mn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 451.00 Mn
10 Resmed 31.89 Bn 25.96 Bn 861.22 Mn 383.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 383.43 Mn
Mar 31, 2026 398.73 Mn
Dec 31, 2025 392.59 Mn
Sep 30, 2025 348.54 Mn
Jun 30, 2025 379.71 Mn
Mar 31, 2025 365.04 Mn
Dec 31, 2024 344.62 Mn
Sep 30, 2024 311.36 Mn
Jun 30, 2024 292.24 Mn
Mar 31, 2024 300.49 Mn
Dec 31, 2023 208.80 Mn
Sep 30, 2023 219.42 Mn
Jun 30, 2023 229.66 Mn
Mar 31, 2023 232.50 Mn
Dec 31, 2022 224.91 Mn
Sep 30, 2022 210.48 Mn
Jun 30, 2022 195.06 Mn
Mar 31, 2022 179.01 Mn
Dec 31, 2021 201.75 Mn
Sep 30, 2021 203.61 Mn
API Access

Resmed Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=RMD&period=max&api_key=YOUR_API_KEY